CLSN - セルシオン (Celsion Corporation) セルシオン

 CLSNのチャート


 CLSNの企業情報

symbol CLSN
会社名 Celsion Corp (セルシオン)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 セルシオン(Celsion Corporation)は治療が難しい癌の患者向けの治療法の開発するを中心とする腫瘍薬品の開発企業。平成23年12月31日現在、同社の主力商品「ThermoDox」は、肝臓癌に対する「HEAT」研究と呼ばれる第3相臨床試験、大腸癌の肝臓転移に対する第2相臨床研究及び再発性胸壁乳癌に対する第2相臨床研究において評価されている。「ThermoDox」はリポソームカプセル化したドキソルビシンであり、各種癌の治療でよく使用される認可を受けた腫瘍薬品である。軽度の温熱療法でのローカライズされた熱はリポソームから封入ドキソルビシンを放出して、高濃度のドキソルビシンが対象となる腫瘍またはその周辺で優先的に堆積されることを可能にする。リポソームは、超顕微鏡で製造された小胞体であり、自然に発生する脂肪が含まれる膜二重層に囲まれた離散的な水系中心コンパートメントを含む。   セルシオンは、米国の医薬品開発会社。癌に苦しむ人々の治療法を開発する。独自の熱活性化リポソ―ム技術をベ―スにタ―ゲットを絞った化学療法腫瘍薬を開発し、商品化に取り組む。主要製品である癌治療薬「サ―モドックス」は、原発性肝癌を対象とした第3相臨床試験と、再発胸壁の乳癌治療を対象にした第2相臨床試験で評価されている。   
本社所在地 997 Lenox Drive Suite 100 Lawrenceville NJ 08648 USA
代表者氏名 Jeffrey Wayne Church ジェフリー・ウェイン教会
代表者役職名 Chief Financial Officer Senior Vice President Corporate Secretary IR Contact Officer
電話番号 +1 609-896-9100
設立年月日 30072
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 19人
url www.celsion.com
nasdaq_url https://www.nasdaq.com/symbol/clsn
adr_tso
EBITDA EBITDA(百万ドル) -20.93515
終値(lastsale) 2.65
時価総額(marketcap) 47027655.25
時価総額 時価総額(百万ドル) 44.59869
売上高 売上高(百万ドル) 0.50000
企業価値(EV) 企業価値(EV)(百万ドル) 27.62501
当期純利益 当期純利益(百万ドル) -23.05973
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Celsion Corporation revenues remained flat at $250K. Net loss applicable to common stockholders increased 22% to $12.7M. Revenues reflect market conditions. Higher net loss reflects Selling General_Administrative increase of 67% to $5.2M (expense) Research and development increase of 12% to $7.3M (expense) Other (expense) income decrease from $3K (income) to $0K.

 CLSNのテクニカル分析


 CLSNのニュース

   Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates  2021/04/01 13:23:01 Benzinga
Celsion Corporation (NASDAQ: CLSN ) has announced a poster highlighting its ongoing Phase 1/2 OVATION 2 Study with GEN-1 in advanced ovarian cancer was presented last week at the Virtual Annual Meeting on Women’s Cancer. GEN-1 is a DNA-mediated interleukin-12 (IL-12) immunotherapy … Full story available on Benzinga.com
   Celsion Corporation Reports 2020 Financial Results and Provides Business Update  2021/03/19 12:45:00 GlobeNewswire
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins…
   Earnings Scheduled For March 19, 2021  2021/03/19 04:08:00 Benzinga
Companies Reporting Before The Bell • Celsion (NASDAQ:CLSN) is projected to report quarterly loss at $0.13 per share on revenue of $120.00 …
   Earnings Previews: FedEx, Luminar, Nike, Celsion  2021/03/17 17:10:43 24/7 Wall street
   Biotech Stock Rips On FDA Fast Track  2021/02/22 20:13:19 Baystreet Canada
A New Jersey-based biotech stock absolutely ripped today after it announced that the company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for GEN-1, its DNA-mediated interleukin-12 immunotherapy. Celsion Corporation’s …
   Biotech Stock Rips On FDA Fast Track  2021/02/22 20:13:19 Baystreet Canada
A New Jersey-based biotech stock absolutely ripped today after it announced that the company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for GEN-1, its DNA-mediated interleukin-12 immunotherapy. Celsion Corporation’s …
   CLSN Stock: Why Biotech Celsion Is Soaring Today  2021/02/22 15:29:31 InvestorPlace
Celsion (CLSN) stock was on the rise Monday after announcing fast-track approval from the U.S. Food and Drug Administration.
   Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech?  2021/02/12 14:31:00 PR Newswire
NEW YORK, Feb. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, CLSN, MARK, PSTV, and SNES. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   CLSN Stock: Why Biotech Company Celsion Is Soaring Today  2021/02/11 16:54:54 InvestorPlace
Celsion (CLSN) stock is rising higher on Thursday after the release of a letter from chairman, president and CEO Michael Tardugno.
   Thinking about buying stock in AMC Entertainment, AzurRx BioPharma, Celsion Corp, Transocean, or Biolase?  2021/01/22 15:50:00 PR Newswire
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, AZRX, CLSN, RIG, and BIOL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Biotech Stock Rips On FDA Fast Track  2021/02/22 20:13:19 Baystreet Canada
A New Jersey-based biotech stock absolutely ripped today after it announced that the company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for GEN-1, its DNA-mediated interleukin-12 immunotherapy. Celsion Corporation’s …
   CLSN Stock: Why Biotech Celsion Is Soaring Today  2021/02/22 15:29:31 InvestorPlace
Celsion (CLSN) stock was on the rise Monday after announcing fast-track approval from the U.S. Food and Drug Administration.
   Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech?  2021/02/12 14:31:00 PR Newswire
NEW YORK, Feb. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, CLSN, MARK, PSTV, and SNES. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   CLSN Stock: Why Biotech Company Celsion Is Soaring Today  2021/02/11 16:54:54 InvestorPlace
Celsion (CLSN) stock is rising higher on Thursday after the release of a letter from chairman, president and CEO Michael Tardugno.
   Thinking about buying stock in AMC Entertainment, AzurRx BioPharma, Celsion Corp, Transocean, or Biolase?  2021/01/22 15:50:00 PR Newswire
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, AZRX, CLSN, RIG, and BIOL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 セルシオン CLSN Celsion Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)